Stock screenerAll disclosures →
EDGAR →
SPRO
Conviction 24HealthcareScan · Thu, Jun 25, 2026SPRO$2.02-3.81%
ResistanceSupportVol 14Insider sellVol MA14 2.25M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price2.02
Change-3.81%
Gap+0.00%
Rel volume1.07×
Avg volume1.84M
Avg $ vol4.37M
SMA 202.60
SMA 502.63
SMA 2002.40
Price vs 50-23.22%
Price vs 200-15.81%
MA stackmixed
50/200 cross—
Supertrenddown · 2.76
RSI (14)33
MACD hist-0.08
MACD cross—
Stoch %K / %D6 / 13
ADX (14)25
+DI / −DI14 / 32
RSI divergence—
MACD divergence—
ATR %+10.85%
ADR %9.01%
52w high3.04
52w low1.83
From 52w high-33.55%
Above 52w low+10.38%
New 52w highNo
SqueezeOff
Bollinger width48.54%
%B0.04
Donchian pos6.27%
Donchian high3.07
Donchian low1.95
AVWAP (52w high)2.41
vs AVWAP high-16.19%
AVWAP (52w low)2.42
vs AVWAP low-16.49%
OBV trendDown
Chaikin MF (20)-0.47
Today vs 20d1.07×
Avg vol (14d)2.25M
Avg vol (20d)1.84M
Avg $ vol (20d)4.37M
Market cap116.96M
RS 3m (vs SPY)-23.65%
RS 6m (vs SPY)-17.22%
RS line new highNo
Trend template3/8
Technical rank14.7
1 week-4.27%
1 month-29.37%
3 months-16.18%
6 months-14.77%
1 year-29.86%
YTD-14.04%
P/E13.64
P/B2.21
P/S9.29
P/FCF-9.15
EPS0.1500
Div yield—
ROE16.19%
ROA14.52%
Debt/Eq—
Current10.50
EV/EBITDA9.63
Gross margin—
Net margin68.11%
Rev growth3292.45%
EPS growth112.50%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value60.83M
Revenue0
Net income-7.2M
Gross profit—
Free cash flow-12.78M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out57.9M
Employees25
ListedThu, Nov 2, 2017
Free float39.79M
Float %70.6%
Short interest1.71M
Days to cover2.0d
Short volume41.4%
Squeeze score20 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction24 / 100
Pattern quality—
Tech rank14.7 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance3.07
Support2.16
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in SPRO
No recent disclosed trades by Congress in SPRO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SPRO · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Deshpande Milind Director · Common Stock · 2026-06-23 | Grant | 10K | — | 2026-06-23 | 2026-06-25 |
Deshpande Milind Director · Stock Option (right to buy) · 2026-06-23 | Grant | 20K | — | 2026-06-23 | 2026-06-25 |
Jackson Scott Thomas Director · Common Stock · 2026-06-23 | Grant | 10K | — | 2026-06-23 | 2026-06-25 |
Jackson Scott Thomas Director · Stock Option (right to buy) · 2026-06-23 | Grant | 20K | — | 2026-06-23 | 2026-06-25 |
THOMAS FRANK E Director · Stock Option (right to buy) · 2026-06-23 | Grant | 20K | — | 2026-06-23 | 2026-06-25 |
VINK PATRICK V.J.J. Director · Common Stock · 2026-06-23 | Grant | 10K | — | 2026-06-23 | 2026-06-25 |
VINK PATRICK V.J.J. Director · Stock Option (right to buy) · 2026-06-23 | Grant | 20K | — | 2026-06-23 | 2026-06-25 |
Tregoning Kathleen Director · Common Stock · 2026-06-23 | Grant | 10K | — | 2026-06-23 | 2026-06-25 |
Tregoning Kathleen Director · Stock Option (right to buy) · 2026-06-23 | Grant | 20K | — | 2026-06-23 | 2026-06-25 |
Smith Cynthia Director · Common Stock · 2026-06-23 | Grant | 10K | — | 2026-06-23 | 2026-06-25 |
SEC filings
EDGAR filings in SPRO · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.